ADAM9 and cancer: In general, the results of the bioinformatics analyses implicated that ADAM9, MTHFD2, RRM2, and SLC2A1 are overexpressed in tumors and that the cumulative effect of their overexpression is associated with poor outcomes in multiple types of cancer.